ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

LYEL Lyell Immunopharma Inc

2.36
-0.04 (-1.67%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Lyell Immunopharma Inc LYEL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.04 -1.67% 2.36 19:00:00
Open Price Low Price High Price Close Price Previous Close
2.44 2.35 2.66 2.36 2.40
more quote information »

Recent News

Date Time Source Heading
3/05/202415:30GLOBELyell Immunopharma Announces the Acceptance of Three..
2/28/202415:07EDGAR2Form 8-K - Current report
2/28/202415:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
2/26/202415:05GLOBELyell Immunopharma Announces Participation in March Investor..
2/13/202419:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202419:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202419:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202415:05GLOBELyell Immunopharma to Participate in 42nd Annual J.P. Morgan..
11/20/202319:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202319:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202319:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202315:26EDGAR2Form 8-K - Current report
11/09/202315:05GLOBELyell Immunopharma Receives FDA Orphan Drug Designation for..
11/07/202315:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202315:08EDGAR2Form 8-K - Current report
11/07/202315:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
10/31/202308:00GLOBELyell Immunopharma Presentations at SITC Highlight New..
9/27/202308:00GLOBELyell Immunopharma Announces the Acceptance of Six Abstracts..
9/11/202308:16EDGAR2Form 8-K - Current report
9/11/202307:00PRNUSCellares and Lyell to Evaluate Automated Manufacturing of..
8/31/202315:05GLOBELyell Immunopharma to Participate in Upcoming Investor..
8/08/202315:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202315:10EDGAR2Form 8-K - Current report
8/08/202315:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
7/05/202315:05GLOBELyell Immunopharma Appoints Matthew Lang as Chief Business..
6/07/202315:05GLOBELyell Immunopharma to Participate in the Goldman Sachs..

Your Recent History

Delayed Upgrade Clock